关注
Jeffrey Weitz
Jeffrey Weitz
Professor of Medicine and Biochemistry and Biomedical Sciences, McMaster University
在 mcmaster.ca 的电子邮件经过验证
标题
引用次数
年份
Reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH: R1
JH Levy, JR Shaw, LA Castellucci, JM Connors, J Douketis, ...
Journal of Thrombosis and Haemostasis, 2024
2024
Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors
S Schulman, V Bhagirath, N Chan, F Germini, R Ikesaka, A Iorio, ...
Journal of Thrombosis and Haemostasis, 2024
2024
Current gaps in the provision of safe and effective anticoagulation in atrial fibrillation and the potential for factor XI-directed therapeutics
SG Goodman, D Roy, CV Pollack Jr, K Leblanc, KF Kwaku, GD Barnes, ...
Critical Pathways in Cardiology 23 (2), 47-57, 2024
12024
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
M Di Nisio, M Candeloro, N Potere, E Porreca, JI Weitz
Bleeding, Thrombosis and Vascular Biology 3 (s1), 2024
2024
Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice
RA Malik, J Zhou, JC Fredenburgh, J Crosby, AS Revenko, JS Healey, ...
Arteriosclerosis, Thrombosis, and Vascular Biology, 2024
12024
Global Health Burden of Venous Thromboembolism
A Wendelboe, JI Weitz
Arteriosclerosis, Thrombosis, and Vascular Biology 44 (5), 1007-1011, 2024
2024
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13
H Madarati, V DeYoung, K Singh, T Sparring, AC Kwong, JC Fredenburgh, ...
Scientific Reports 14 (1), 9073, 2024
2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper
J Harenberg, RC Gosselin, A Cuker, C Becattini, I Pabinger, S Poli, ...
Thrombosis and haemostasis, 2024
52024
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial
JI Weitz, LB Tankó, J Floege, KAA Fox, DL Bhatt, R Thadhani, J Hung, ...
Nature Medicine 30 (2), 435-442, 2024
62024
Human platelets contain a pool of free zinc in dense granules
WHA Kahr, SJ Henderson, FG Pluthero, HFG Heijnen, N Vaezzadeh, ...
Research and Practice in Thrombosis and Haemostasis 8 (2), 102352, 2024
12024
Direct oral anticoagulation versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves: a retrospective, real-world cohort study
R Eikelboom, RP Whitlock, S Sibilio, F Nguyen, R Perez, JI Weitz, ...
Cardiovascular Drugs and Therapy 38 (1), 109-117, 2024
12024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
A Bejjani, CD Khairani, A Assi, G Piazza, P Sadeghipour, AH Talasaz, ...
Journal of the American College of Cardiology 83 (3), 444-465, 2024
32024
Vascular closure devices and methods providing hemostatic enhancement
Z Yassinzadeh, JI Weitz, A Stafford
US Patent 11,871,916, 2024
2024
Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model
JE Chessum, SA Shaya, D Rajab, A Aftabjahani, J Zhou, JI Weitz, ...
Journal of Thrombosis and Haemostasis 22 (1), 263-270, 2024
2024
PAR4 inhibition reduces coronary artery atherosclerosis and myocardial fibrosis in SR-B1/LDLR double knockout mice
SK Lee, RA Malik, J Zhou, W Wang, PL Gross, JI Weitz, R Ramachandran, ...
Arteriosclerosis, thrombosis, and vascular biology 43 (11), 2165-2178, 2023
52023
Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-Care in Symptomatic …
TS Field, V Dizonno, MA Almekhlafi, F Bala, I Alhabli, H Wong, M Norena, ...
Stroke 54 (11), 2724-2736, 2023
172023
OC 31.3 Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VMX-C001 in Healthy Subjects
G Short, D Verhoef, T Gomes, H Spronk, J Ohrstrom, B Persson, J Weitz, ...
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
PB0543 Like Heparin, Polyphosphate Promotes the Formation of a Ternary Complex with Thrombin and Fibrin
X Yao, J Fredenburgh, J Weitz
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
PB0014 Do Antiphospholipid Antibodies Inform the Choice of Anticoagulant Agents in Patients with Atrial Fibrillation?
B Bikdeli, A Bejjani, C Khairani, D Jimenez, M Monreal, D Siegal, Y Kanthi, ...
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
OC 45.5 The Lethality in Mice Treated with Intravenous Polyphosphate is Not Due to Thrombosis
R Malik, J Zhou, J Fredenburgh, J Healey, J Weitz
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20